PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Pitt, Bertram
TI  - EMPHASIS-HF: An Analysis of the High-Risk Groups
DP  - 2011 Nov 01
TA  - MD Conference Express
PG  - 14--15
VI  - 11
IP  - 10
4099  - http://mdc.sagepub.com/content/11/10/14.short
4100  - http://mdc.sagepub.com/content/11/10/14.full
AB  - Recent results from the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure [EMPHASIS-HF] trial showed that eplerenone, compared with placebo, significantly reduced the risk of the composite of cardiovascular death and hospitalization for heart failure in patients with chronic systolic NYHA class II HF [NCT00232180; Zannad F et al. N Engl J Med 2011].